🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Iovance Biotherapeutics, Inc. (IOVA)
NASDAQ: IOVA · Real-Time Price · USD
7.48
-0.05 (-0.66%)
At close: Nov 18, 2026, 4:00 PM EST
7.43
-0.05 (-0.67%)
After-hours: Nov 18, 2026, 6:41 PM EST

Iovance Biotherapeutics Statistics

Total Valuation

IOVA has a market cap or net worth of $3.46 billion. The enterprise value is $3.13 billion.

Market Cap3.46B
Enterprise Value 3.13B

Important Dates

The last earnings date was Thursday, November 5, 2026, before market open.

Earnings Date Nov 5, 2026
Ex-Dividend Date n/a

Share Statistics

IOVA has 462.66 million shares outstanding. The number of shares has increased by 30.80% in one year.

Current Share Class 462.66M
Shares Outstanding 462.66M
Shares Change (YoY) +30.80%
Shares Change (QoQ) +1.27%
Owned by Insiders (%) 6.42%
Owned by Institutions (%) 54.99%
Float 403.97M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 9.10
Forward PS 6.17
PB Ratio 4.29
P/TBV Ratio 6.23
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings n/a
EV / Sales 8.23
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF n/a

Financial Position

The company has a current ratio of 5.20, with a Debt / Equity ratio of 0.06.

Current Ratio 5.20
Quick Ratio 4.57
Debt / Equity 0.06
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage n/a

Financial Efficiency

Return on equity (ROE) is -29.11% and return on invested capital (ROIC) is -17.86%.

Return on Equity (ROE) -29.11%
Return on Assets (ROA) -15.19%
Return on Invested Capital (ROIC) -17.86%
Return on Capital Employed (ROCE) -26.02%
Weighted Average Cost of Capital (WACC) 8.74%
Revenue Per Employee $388,701
Profits Per Employee -$226,190
Employee Count975
Asset Turnover 0.40
Inventory Turnover 3.31

Taxes

Income Tax -1.24M
Effective Tax Rate n/a

Stock Price Statistics

The stock price has increased by +209.09% in the last 52 weeks. The beta is 0.84, so IOVA's price volatility has been lower than the market average.

Beta (5Y) 0.84
52-Week Price Change +209.09%
50-Day Moving Average 11.27
200-Day Moving Average 6.19
Relative Strength Index (RSI) 31.51
Average Volume (20 Days) 15,147,838

Short Selling Information

The latest short interest is 65.19 million, so 14.09% of the outstanding shares have been sold short.

Short Interest 65.19M
Short Previous Month 58.93M
Short % of Shares Out 14.09%
Short % of Float 16.14%
Short Ratio (days to cover) 4.24

Income Statement

In the last 12 months, IOVA had revenue of $378.98 million and -$220.54 million in losses. Loss per share was -$0.51.

Revenue378.98M
Gross Profit 201.75M
Operating Income -230.38M
Pretax Income -221.78M
Net Income -220.54M
EBITDA -192.91M
EBIT -230.38M
Loss Per Share -$0.51
Full Income Statement

Balance Sheet

The company has $376.32 million in cash and $45.21 million in debt, with a net cash position of $331.11 million or $0.72 per share.

Cash & Cash Equivalents 376.32M
Total Debt 45.21M
Net Cash 331.11M
Net Cash Per Share $0.72
Equity (Book Value) 812.66M
Book Value Per Share 1.76
Working Capital 443.86M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$189.95 million and capital expenditures -$26.11 million, giving a free cash flow of -$216.06 million.

Operating Cash Flow -189.95M
Capital Expenditures -26.11M
Depreciation & Amortization 37.47M
Net Borrowing n/a
Free Cash Flow -216.06M
FCF Per Share -$0.47
Full Cash Flow Statement

Margins

Gross margin is 53.23%, with operating and profit margins of -60.79% and -58.19%.

Gross Margin 53.23%
Operating Margin -60.79%
Pretax Margin -58.52%
Profit Margin -58.19%
EBITDA Margin -50.90%
EBIT Margin -60.79%
FCF Margin n/a

Dividends & Yields

IOVA does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
FCF Payout Ratio n/a
Buyback Yield -30.80%
Shareholder Yield -30.80%
Earnings Yield -6.80%
FCF Yield -6.26%

Analyst Forecast

The average price target for IOVA is $14.50, which is 93.85% higher than the current price. The consensus rating is "Buy".

Price Target $14.50
Price Target Difference 93.85%
Analyst Consensus Buy
Analyst Count 9
Revenue Growth Forecast (3Y) 52.11%
EPS Growth Forecast (3Y) n/a
Stock Forecasts

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a
Graham Formula Value n/a
Graham Formula Upside n/a

Stock Splits

The last stock split was on September 26, 2013. It was a reverse split with a ratio of 1:100.

Last Split Date Sep 26, 2013
Split Type Reverse
Split Ratio 1:100

Scores

IOVA has an Altman Z-Score of 1.98 and a Piotroski F-Score of 4. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.98
Piotroski F-Score 4